Pyridine compounds and their use as P2Y12 antagonists.

Details for Australian Patent Application No. 2008203953 (hide)

Owner AstraZeneca AB

Inventors Giordanetto, Fabrizio; Johansson, Johan; Antonsson, Thomas; Bach, Peter; Bylund, Ruth; Brown, David

Agent Davies Collison Cave

Pub. Number AU-A-2008203953

PCT Pub. Number WO2008/085117

Priority 60/884,658 12.01.07 US

Filing date 11 January 2008

Wipo publication date 17 July 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61K 31/4545 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/085117 Priority application(s): WO2008/085117

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203958-Process for the production of chlorine dioxide

2008203934-Nitride nanowires and method of producing such